Key Pharma Stock Updates: Merck, BeOne, MeiraGTx, MannKind, and Fulcrum

Wells Fargo upgrades Merck to Overweight; Truist and H.C. Wainwright initiate coverage on BeOne Medicines, MeiraGTx, MannKind, and Fulcrum with Buy ratings and promising price targets.